MedPage Today on MSN
1.8 billion MASLD cases; improving HCC surveillance; ultrasound for Crohn's disease
News and commentary from the world of gastroenterology and hepatology ...
Gender and ethnic disparities in hepatocellular carcinoma: Trends in incidence rates across U.S. populations from 2000 to 2021. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...
Researchers measured the annual prevalence of cirrhosis, decompensated cirrhosis and HCC in a sample of HCV veterans from 1996-2006. Results demonstrated the number of HCV patients increased from ...
Hepatocellular carcinoma (HCC), the most common type of liver cancer, affects women and men at similar rates in Mexico; however, men are more likely to present with the disease in an advanced stage, ...
"HCC remains a major public health issue, disproportionately affecting minority populations and metropolitan US regions. Although multiple risk factors could also contribute to the mortality in ...
Neoadjuvant immune checkpoint inhibitor (ICI) therapy may enable patients with high-risk hepatocellular carcinoma (HCC) to achieve outcomes similar to those undergoing upfront surgery. Administering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results